ArticleCancer reports (Hoboken, N.J.)2024

Metastatic Non-Myofibroblastic Sarcoma Harbouring EML4-ALK Fusion-Dramatic Response to ALK Tyrosine Kinase Inhibitors and Development of Resistance Mutations.

Isabella Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.